Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 20/20 | 0.87 |
| ▸ | GABRP | O00591 | 2/20 | 0.79 |
| ▸ | GABRD | O14764 | 2/20 | 0.79 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.79 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.79 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.79 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.79 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.79 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.79 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.79 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.79 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.79 |
| ▸ | GABRE | P78334 | 2/20 | 0.79 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.79 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.79 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.79 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.79 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.79 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.79 |
| ▸ | PGR | P06401 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL547156 | 1.00 | AR (0.87) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL547539 | 0.98 | AR (0.87) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL29861461 | 0.98 | AR (0.87) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL15661295 | 0.98 | AR (0.85) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL17107302 | 0.98 | AR (0.85) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL17107300 | 0.95 | AR (0.78) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL17117389 | 0.95 | AR (0.78) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL17117368 | 0.95 | AR (0.78) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL17107295 | 0.94 | AR (0.85) | ARGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL14930979 | 0.93 | AR (1.00) | ARGABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 737 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260143902-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-05-21 | — | — | US | claimed |
| CN-122070133-A | Pharmaceutical compositions containing androgen receptor inhibitors/antagonists, methods and uses | 苏州开拓药业股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12628547-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-05-12 | — | — | US | claimed |
| EP-4735045-A2 | OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE | La Life Products, LLC (US) | 2026-05-06 | — | — | EP | claimed |
| US-20260123268-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260123266-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260123269-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260096280-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-02 | — | — | US | claimed |
| US-20260090187-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-03-26 | — | — | US | claimed |
| US-20260090195-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-03-26 | — | — | US | claimed |
| EP-4001286-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2022-05-25 | — | — | EP | claimed |
| US-20220135605-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-05-05 | — | — | US | claimed |
| US-20220112228-A1 | ORGANIC ELECTROLUMINESCENT MATTERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-04-14 | — | — | US | claimed |
| US-20220106342-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-04-07 | — | — | US | claimed |
| US-20220106344-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-04-07 | — | — | US | claimed |
| US-20220106343-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-04-07 | — | — | US | claimed |
| US-20220089625-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-03-24 | — | — | US | claimed |
| US-20220085302-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-03-17 | — | — | US | claimed |
| US-20220052275-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-02-17 | — | — | US | claimed |
| EP-3946629-A1 | THERAPEUTIC TARGETS FOR ONCOGENIC KRAS-DEPENDENT CANCERS | University Of Massachusetts (US) | 2022-02-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (16 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220106342-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, OCIAD1, OCIAD2 | AR 315/4885GABRP 3219/4885GABRD 3432/4885 |
| US-20220106344-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | CTCF, CCNY, RUVBL2 | AR 651/4885GABRP 1812/4885GABRD 1331/4885 |
| US-20220106343-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ICOSLG | AR 2195/4885GABRP 3902/4885GABRD 3846/4885 |
| US-20260090195-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRA1, GLRB | AR 120/4885GABRP 242/4885GABRD 521/4885 |
| US-20260123269-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, LDLR, MLX | AR 301/4885GABRP 2142/4885GABRD 2407/4885 |
| US-20260143902-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRB, LIFR | AR 95/4885GABRP 326/4885GABRD 526/4885 |
| US-20260123268-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | GLRA1, LBR, GLRB | AR 47/4885GABRP 619/4885GABRD 817/4885 |
| US-20220112228-A1 | ORGANIC ELECTROLUMINESCENT MATTERIALS AND DEVICES | OCIAD1, OCIAD2, L1CAM | AR 2164/4885GABRP 4334/4885GABRD 4218/4885 |
| US-20220135605-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, TRPA1 | AR 1892/4885GABRP 3459/4885GABRD 3940/4885 |
| US-20220089625-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, ODC1 | AR 2437/4885GABRP 3477/4885GABRD 3817/4885 |
| US-20260096280-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | GLRA1, GLRA3, MSR1 | AR 238/4885GABRP 1495/4885GABRD 2528/4885 |
| US-12628547-B2 | Organic electroluminescent materials and devices | ZYX, PYM1, MSL1 | AR 1100/4885GABRP 2099/4885GABRD 3778/4885 |
| US-20220085302-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LIFR, LBR, EPOR | AR 126/4885GABRP 1311/4885GABRD 1137/4885 |
| US-20220052275-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OTC | AR 3499/4885GABRP 4450/4885GABRD 3678/4885 |
| US-20260090187-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | GLRA1, LBR, GLRB | AR 89/4885GABRP 432/4885GABRD 746/4885 |
| US-20260123266-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, LDLR, GLRB | AR 119/4885GABRP 383/4885GABRD 367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.